End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83,500 KRW | +0.24% | +0.97% | -16.83% |
01-30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
Business Summary
Number of employees: 252
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drug Development
100.0
%
| 246,179 | 100.0 % | 354,892 | 100.0 % | +44.16% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
143.4
%
| 388,212 | 157.7 % | 508,889 | 143.4 % | +31.09% |
Consolidated Adjustment
-130.9
%
| -356,974 | -145.0 % | -464,702 | -130.9 % | +30.18% |
South Korea
87.5
%
| 214,941 | 87.3 % | 310,705 | 87.5 % | +44.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 31/12/22 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 31/12/22 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 15/03/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 15/03/17 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 15/03/17 |
Young-Ju Bang
BRD | Director/Board Member | - | 26/08/19 |
Hae-Young Ahn
BRD | Director/Board Member | - | 26/08/19 |
Min-Seop Song
BRD | Director/Board Member | 54 | 26/08/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,313,250 | 27,996,731 ( 35.75 %) | 0 | 35.75 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.83% | 4.75B | |
+4.02% | 70.44B | |
+10.97% | 8.94B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A326030 Stock
- Company SK Biopharmaceuticals Co., Ltd.